Bellevue Group Ag Homology Medicines, Inc. Transaction History

Bellevue Group Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.39 - $3.12 $34,194 - $76,752	-24,600 Reduced 1.49%	1,622,522 $3.2 Million
Q1 2022 May 13, 2022	SELL	$2.6 - $4.17 $234,000 - $375,300	-90,000 Reduced 5.18%	1,647,122 $5.01 Million
Q2 2020 Aug 13, 2020	BUY	$12.07 - $19.34 $1.51 Million - $2.42 Million	125,000 Added 7.75%	1,737,122 $26.4 Million
Q3 2019 Nov 14, 2019	BUY	$14.74 - $22.28 $3.1 Million - $4.68 Million	210,000 Added 14.98%	1,612,122 $29.2 Million
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $25.7 Million - $42.5 Million	1,402,122 New	1,402,122 $27.4 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.